Royce & Associates LP lowered its position in Arcosa, Inc. (NYSE:ACA - Free Report) by 9.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,239,249 shares of the company's stock after selling 128,525 shares during the period. Arcosa makes up about 1.1% of Royce & Associates LP's investment portfolio, making the stock its biggest position. Royce & Associates LP owned approximately 2.54% of Arcosa worth $119,885,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Swiss National Bank raised its position in Arcosa by 1.2% during the fourth quarter. Swiss National Bank now owns 96,000 shares of the company's stock worth $9,287,000 after acquiring an additional 1,100 shares during the last quarter. HighTower Advisors LLC increased its stake in shares of Arcosa by 0.4% during the 4th quarter. HighTower Advisors LLC now owns 72,916 shares of the company's stock worth $7,054,000 after purchasing an additional 284 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Arcosa by 22.2% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,797 shares of the company's stock worth $1,528,000 after purchasing an additional 2,871 shares during the last quarter. AlphaQuest LLC lifted its stake in Arcosa by 12,050.0% in the 4th quarter. AlphaQuest LLC now owns 729 shares of the company's stock valued at $71,000 after buying an additional 723 shares in the last quarter. Finally, Amundi grew its holdings in Arcosa by 191.1% during the 4th quarter. Amundi now owns 25,000 shares of the company's stock valued at $2,375,000 after buying an additional 16,412 shares during the last quarter. 90.66% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, Oppenheimer raised their price target on Arcosa from $105.00 to $110.00 and gave the stock an "outperform" rating in a research report on Tuesday, January 14th.
View Our Latest Research Report on ACA
Arcosa Trading Down 1.9 %
Shares of NYSE ACA traded down $1.57 during midday trading on Thursday, reaching $80.25. 247,982 shares of the stock were exchanged, compared to its average volume of 242,405. The stock has a 50 day moving average price of $93.41 and a 200-day moving average price of $96.33. The company has a current ratio of 3.61, a quick ratio of 2.77 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $3.91 billion, a P/E ratio of 30.51 and a beta of 0.81. Arcosa, Inc. has a 52-week low of $72.75 and a 52-week high of $113.43.
Arcosa Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Tuesday, April 15th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.25%. The ex-dividend date is Tuesday, April 15th. Arcosa's dividend payout ratio (DPR) is 10.47%.
Arcosa Company Profile
(
Free Report)
Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.
See Also

Before you consider Arcosa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arcosa wasn't on the list.
While Arcosa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.